RecruitingNot ApplicableNCT06261658

Improving the Quality of Cryopreserved Ovarian Tissue Reimplantation Using Platelet-enriched Autologous Plasma

Sponsor

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Enrollment

45 participants

Start Date

Mar 1, 2024

Study Type

INTERVENTIONAL

Conditions

Cryopreservation Infertility, Female Ovary Injury Menopause Ovarian Failure

Summary

The study is aimed to evaluate the effects of intraovarian injection of autologous Platelet-enriched Autologous Plasma on the outcomes of orthotopic transplantation of cryopreserved ovarian tissue.

Eligibility

Sex: FEMALE

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called Cryopreserved Ovarian Tissue Reimplantation for people with cryopreservation, infertility, female, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include women.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.